PSP Research »

Maze Therapeatics shares owned by PSP Research

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by PSP Research

Quarter filed Position value Share count Share price at filing
2025-12-31 $525k 13k 41.43

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Praxis Precision Medicines I Com New (PRAX)
Travere Therapeutics (TVTX)
Tyra Biosciences (TYRA)
Pharvaris N V (PHVS)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Celldex Therapeutics Com New (CLDX)
Cg Oncology (CGON)
Belite Bio Sponsored Ads (BLTE)
Ascendis Pharma A/s Sponsored Adr (ASND)
Apellis Pharmaceuticals (APLS)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Bridgebio Pharma (BBIO)

View all positions for PSP Research

Top funds holding Maze Therapeatics

Frazier Life Sciences Management
Trv Gp Iv
Deep Track Capital
Arch Venture Corp
BlackRock
AH Capital Management
Vanguard Group
VR Adviser
Alphabet
General Catalyst Group Management
Woodline Partners
TRV GP V
Logos Global Management
Bellevue Group
Marshall Wace

View all funds holding Maze Therapeatics